Parallel Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Parallel Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-145	Closed	-$7K	–	3609
2022 Q3	$7K	Sell	145 -21,184	-99%	-$876K	﹤0.01%	2178
2022 Q2	$529K	Sell	21,329 -11	-0.1%	-$242	0.02%	376
2022 Q1	$534K	Buy	21,340 +21,000	+6,176%	+$590K	0.02%	409
2021 Q4	$12K	Buy	340 +154	+83%	+$5.41K	﹤0.01%	2049
2021 Q3	$3K	Buy	+186	New	+$2.9K	﹤0.01%	2625
2021 Q2	–	Sell	-35	Closed	-$2K	–	3125
2021 Q1	$2K	Hold	35	–	–	﹤0.01%	2551
2020 Q4	$2K	Hold	35	–	–	﹤0.01%	2376
2020 Q3	$2K	Buy	35 +5	+17%	+$269	﹤0.01%	2377
2020 Q2	$1K	Buy	+30	New	+$1.63K	﹤0.01%	2404

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallel Advisors's CCXI Position: Q4 2022 in Review

Parallel Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 145 shares — an estimated $7K sold.

Parallel Advisors first reported a position in CCXI in Q2 2020 and held it in 9 quarters. The position peaked at $534K in Q1 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Parallel Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Parallel Advisors sold 145 ChemoCentryx, Inc. shares in Q4 2022, an estimated $7K.
Parallel Advisors first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 9 quarters.
Parallel Advisors's ChemoCentryx, Inc. position peaked at $534K in Q1 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.